Loading clinical trials...
Loading clinical trials...
Fibrosing interstitial lung diseases (FILDs) encompass a group of rare diseases characterized by progressive pulmonary fibrosis leading to respiratory failure. Current treatments primarily aim to slow...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hospices Civils de Lyon
NCT07572383 · Interstitial Lung Disease, Pulmonary Fibrosis
NCT05139719 · Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)
NCT05746039 · Obesity, Interstitial Lung Disease, and more
NCT06329401 · Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, and more
NCT07451977 · Chronic Respiratory Failure, Hypoxemia, and more
Hôpital Cardiologique et Pneumologique Louis Pradel
Bron, Rhone
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions